ACLX20250516C45
ACLX May 16 2025 45.00 Call (ACLX250516C00045000)
option OPRA

Arcellx Inc. is a clinical-stage biotechnology company. The Company is focused developing controllable cell therapies for the treatment of patients with cancer and other incurable diseases.